Metformin inhibits tumorigenesis in HBV ‐induced hepatocellular carcinoma by suppressing HULC overexpression caused by HBX
Conclusion: This study indicated that metformin imposed inhibitory effect on the HBV‐associated HCC by negatively regulating the HULC /p18/miR‐200a/ZEB1 signaling pathway. This article is protected by copyright. All rights reserved
Source: Journal of Cellular Biochemistry - Category: Biochemistry Authors: Zhen Jiang, Haichao Liu Tags: Article Source Type: research
More News: Biochemistry | Cancer & Oncology | Carcinoma | Fortamet | Hepatocellular Carcinoma | Liver Cancer | Metformin | Study